Clinical trial
LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated…
NCT00167869 · Wageningen University, Other · Completed
Key facts
| NCT number | NCT00167869 |
|---|---|
| Title | LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects. |
| Official title | LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects. |
| Lead sponsor | Wageningen University, Other |
| Collaborators | Unilever R&D Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Behavioral |
| Interventions | dairy peptides |
| Enrollment | 135 |
| Start date | Jun 1, 2004 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Sep 14, 2005 |
| Last update posted | May 29, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: